149 related articles for article (PubMed ID: 2362794)
21. Radiotherapy for laryngeal cancer in patients under 50 years old.
Shimizu W; Ogino T; Ebihara S; Ikeda H
Jpn J Clin Oncol; 1995 Dec; 25(6):258-60. PubMed ID: 8523822
[TBL] [Abstract][Full Text] [Related]
22. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
[TBL] [Abstract][Full Text] [Related]
23. [Results of treatment for laryngeal carcinoma in Würzburg].
Bohndorf W; Höcker G
Strahlentherapie; 1976 Feb; 151(2):132-43. PubMed ID: 1258083
[TBL] [Abstract][Full Text] [Related]
24. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
25. [Cancer of the larynx in Ecuador].
Pacheco-Ojeda L; de la Torre M; Guerrón M; Letort M
Acta Otorrinolaringol Esp; 1997 Apr; 48(3):215-9. PubMed ID: 9235036
[TBL] [Abstract][Full Text] [Related]
26. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
Reddy SP; Hong RL; Nagda S; Emami B
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
[TBL] [Abstract][Full Text] [Related]
27. [Prospective clinical study of twice-a-day fractionation radiotherapy in head and neck cancer].
Okawa T; Akita Y; Hattori H; Takanaka T; Kashihara K; Kita M
Gan No Rinsho; 1988 Oct; 34(13):1768-72. PubMed ID: 3199513
[TBL] [Abstract][Full Text] [Related]
28. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
29. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
30. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
[TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy of carcinoma of the larynx--dose and function preservation].
Nakano M; Iida K; Sato S; Sakata S; Sueyama H
Gan No Rinsho; 1985 Sep; 31(12):1602-4. PubMed ID: 4079049
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy for cancer of the larynx: review of a community hospital experience.
Chung CK; Chung JS; Brace KC; Modlin B
Md Med J; 1994 Nov; 43(11):971-5. PubMed ID: 7808200
[TBL] [Abstract][Full Text] [Related]
33. Results of radiotherapy of carcinoma laryngis in relation to the mode of dose fractionation.
Durkovský J; Sevcíková L; Miklánková M
Neoplasma; 1981; 28(5):599-609. PubMed ID: 7312078
[TBL] [Abstract][Full Text] [Related]
34. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.
Murakami R; Nishimura R; Baba Y; Furusawa M; Ogata N; Yumoto E; Yamashita Y
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):471-5. PubMed ID: 15667969
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time.
Yamazaki H; Nishiyama K; Tanaka E; Koizumi M; Chatani M
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):77-82. PubMed ID: 16169681
[TBL] [Abstract][Full Text] [Related]
37. [Significance of preventive radiotherapy of the neck in clinically N0 tumors of the larynx].
Baroncelli G; Bonetti B; La Face B; Moretti R
Radiol Med; 1988 May; 75(5):528-33. PubMed ID: 3375496
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
39. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study of laryngeal cancer].
Higuchi E; Iizuka K; Shouda H; Takeichi N
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):385-94. PubMed ID: 8934773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
